Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04562870 |
| Consolidated Lead Sponsor | Karyopharm Therapeutics |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 112 participants (ESTIMATED) |
| Registered Start Date | 2021-03-17 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Texas Oncology (Tyler) | Tyler, TX | Open Hospital Dossier -> |
| Peking Union Medical College Hospital | Beijing, China | Open Hospital Dossier -> |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, China | Open Hospital Dossier -> |
| Affiliated Hospital of Nantong University | Nantong, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.